Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
15.89%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.37Close
$ 1.9 - $ 3.9 52-Week Range
Ticker Information
Ticker
LSTACompany Name
LISATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLISATA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LSTA - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 170K | 15.89% | $ 1.07M |
| 3/31/2025 | $ 171K | 17.1% | $ 1M |
| 12/31/2024 | $ 174K | 17.4% | $ 1M |
| 9/30/2024 | $ 180K | 0% | $ 0 |
| 6/30/2024 | $ 185K | 0% | $ 0 |
| 3/31/2024 | $ 187K | 0% | $ 0 |
| 12/31/2023 | $ 189K | 0% | $ 0 |
| 9/30/2023 | $ 189K | 0% | $ 0 |
| 6/30/2023 | $ 150K | 0% | $ 0 |
| 3/31/2023 | $ 110K | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- LISATA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, LISATA THERAPEUTICS INC's average DepAmor % has been 16.8%.
- The median DepAmor % for LISATA THERAPEUTICS INC during this period was 17.1%
- LISATA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 17.4%.
- The lowest DepAmor % recorded by LISATA THERAPEUTICS INC in the same timeframe 15.89%
LISATA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for LISATA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 61K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] LSTA - Depreciation and Amortization Margin, Last 5 years
15.89%
Minimum
Jun 30, 2025
17.4%
Maximum
Dec 31, 2024
16.8%
Average
17.1%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |